Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Patterson Companies, Inc.    PDCO

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

PATTERSON : Companies 3rd Quarter Fiscal 2011 Conference Call Scheduled for February 24

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/10/2011 | 02:35pm CET

Patterson Companies (Nasdaq: PDCO) today announced that it will hold its conference call to review operating results for the third quarter of fiscal 2011 on Thursday, February 24 at 10:00 AM Eastern. The Patterson earnings release will be issued before the market opens that day.

Investors can access a live webcast of the conference call by visiting the investor relations section of the Patterson Companies website, www.PattersonCompanies.com. The webcast will be archived on Patterson's website. Following the conference call, a replay will be available for one week. Interested persons may dial 303-590-3030 and provide the Conference ID, 4411978, when prompted.

About Patterson Companies, Inc.
Patterson Companies, Inc. is a value-added distributor serving the dental, companion-pet veterinarian and rehabilitation supply markets.
Dental Market
As Patterson's largest business, Patterson Dental provides a virtually complete range of consumable dental products, equipment and software, turnkey digital solutions and value-added services to dentists and dental laboratories throughout North America.
Veterinary Market
Webster Veterinary is the nation's second largest distributor of consumable veterinary supplies, equipment and software, diagnostic products, vaccines and pharmaceuticals to companion-pet veterinary clinics.
Rehabilitation Market
Patterson Medical is the world's leading distributor of rehabilitation supplies and non-wheelchair assistive patient products to the physical and occupational therapy markets. The unit's global customer base includes hospitals, long-term care facilities, clinics and dealers.

Patterson Companies
R. Stephen Armstrong
Executive Vice President & CFO
651-686-1600
or
Equity Market Partners
Richard G. Cinquina
904-415-1415


© Business Wire 2011
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on PATTERSON COMPANIES, INC.
11/21 PATTERSON COMPANIES, INC. (NASDAQ : PDCO) Files An 8-K Results of Operations and..
11/21 PATTERSON COMPANIES, INC. : Results of Operations and Financial Condition, Finan..
11/21 PATTERSON : Reports Fiscal 2018 Second-Quarter Results
11/09 PATTERSON : Second-Quarter Fiscal 2018 Conference Call Scheduled for Tuesday, No..
10/26 PATTERSON : Veterinary Partners With Cutting Edge Laser Technologies
10/25 PATTERSON : Names New President and CEO
10/25 PATTERSON : Cos. (PDCO) Appoints Mark Walchirk President and CEO
10/24 PATTERSON COMPANIES, INC. (NASDAQ : PDCO) Files An 8-K Departure of Directors or..
10/24 PATTERSON COMPANIE : ' Newest Shareholder Is ... PETA!
10/24 PATTERSON COMPANIES, INC. : Change in Directors or Principal Officers, Regulatio..
More news
News from SeekingAlpha
11/22 Patterson's (PDCO) CEO Mark Walchirk on Q2 2018 Results - Earnings Call Trans..
11/21 Patterson Companies Inc. 2018 Q2 - Results - Earnings Call Slides
11/21 Patterson misses by $0.03, misses on revenue
11/20 Notable earnings before Tuesday?s open
11/16 Premarket analyst action - healthcare
Financials ($)
Sales 2018 5 603 M
EBIT 2018 353 M
Net income 2018 189 M
Debt 2018 1 021 M
Yield 2018 3,10%
P/E ratio 2018 17,39
P/E ratio 2019 15,32
EV / Sales 2018 0,78x
EV / Sales 2019 0,74x
Capitalization 3 330 M
Chart PATTERSON COMPANIES, INC.
Duration : Period :
Patterson Companies, Inc. Technical Analysis Chart | PDCO | US7033951036 | 4-Traders
Technical analysis trends PATTERSON COMPANIES, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 14
Average target price 41,0 $
Spread / Average Target 18%
EPS Revisions
Managers
NameTitle
James W. Wiltz President, Chief Executive Officer & Director
John Dean Buck Chairman
Sean M. Muniz Vice President-Operations
Ann B. Gugino Chief Financial Officer, Treasurer & Executive VP
Dave Lardy Chief Information Officer
Sector and Competitors
1st jan.Capitalization (M$)
PATTERSON COMPANIES, INC.-12.16%3 330
COLOPLAST A/S6.45%15 874
HENRY SCHEIN-8.88%10 668
CANTEL MEDICAL CORP.31.62%4 419
AMPLIFON SPA33.81%3 415
MERIT MEDICAL SYSTEMS, INC.58.11%2 186